{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T20:11:32Z","timestamp":1762459892678},"reference-count":121,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T00:00:00Z","timestamp":1635897600000},"content-version":"vor","delay-in-days":470,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T00:00:00Z","timestamp":1595289600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T00:00:00Z","timestamp":1595289600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-caused coronavirus disease 2019 (COVID-19) pandemic has become a global health crisis with an extremely rapid progress resulting in thousands of patients who may develop acute respiratory distress syndrome (ARDS) requiring intensive care unit (ICU) treatment. So far, no specific antiviral therapeutic agent has been demonstrated to be effective for COVID-19; therefore, the clinical management is largely supportive and depends on the patients\u2019 immune response leading to a cytokine storm followed by lung edema, dysfunction of air exchange, and ARDS, which could lead to multiorgan failure and death. Given that human mesenchymal stem cells (MSCs) from various tissue sources have revealed successful clinical outcomes in many immunocompromised disorders by inhibiting the overactivation of the immune system and promoting endogenous repair by improving the microenvironment, there is a growing demand for MSC infusions in patients with COVID-19-related ARDS in the ICU. In this review, we have documented the rationale and possible outcomes of compassionate use of MSCs, particularly in patients with SARS-CoV-2 infections, toward proving or disproving the efficacy of this approach in the near future. Many centers have registered and approved, and some already started, single-case or phase I\/II trials primarily aiming to rescue their critical patients when no other therapeutic approach responds. On the other hand, it is also very important to mention that there is a good deal of concern about clinics offering unproven stem cell treatments for COVID-19. The reviewers and oversight bodies will be looking for a balanced but critical appraisal of current trials.<\/jats:p>\n               <jats:sec>\n                  <jats:title \/>\n               <\/jats:sec>","DOI":"10.1002\/sctm.20-0164","type":"journal-article","created":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T01:29:01Z","timestamp":1595381341000},"page":"1287-1302","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["The rationale of using mesenchymal stem cells in patients with COVID-19-related acute respiratory distress syndrome: What to expect"],"prefix":"10.1093","volume":"9","author":[{"given":"Alp","family":"Can","sequence":"first","affiliation":[{"name":"Laboratory for Stem Cells and Reproductive Cell Biology, Department of Histology and Embryology Ankara University Faculty of Medicine 1 , Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hakan","family":"Coskun","sequence":"additional","affiliation":[{"name":"Harvard Medical School 2 , Boston, Massachusetts, USA"},{"name":"Department of Cardiology Boston Children\u2019s Hospital 3 , Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,7,21]]},"reference":[{"key":"2022061708582415200_sct312784-bib-0001","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.tim.2016.03.003","article-title":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses","volume":"24","author":"Su","year":"2016","journal-title":"Trends Microbiol"},{"key":"2022061708582415200_sct312784-bib-0002"},{"key":"2022061708582415200_sct312784-bib-0003"},{"key":"2022061708582415200_sct312784-bib-0004","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA"},{"key":"2022061708582415200_sct312784-bib-0005","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2020-0702","article-title":"Epidemiology of COVID-19 among children in China","volume":"145","author":"Dong","year":"2020","journal-title":"Pediatrics"},{"key":"2022061708582415200_sct312784-bib-0006","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s11684-020-0767-8","article-title":"Coronavirus disease 2019 (COVID-19): a clinical update","volume":"14","author":"Zhou","year":"2020","journal-title":"Front Med"},{"key":"2022061708582415200_sct312784-bib-0007","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa2001316","article-title":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia","volume":"382","author":"Li","year":"2020","journal-title":"N Engl J Med"},{"key":"2022061708582415200_sct312784-bib-0008","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"2022061708582415200_sct312784-bib-0009","first-page":"1199","article-title":"CT image visual quantitative evaluation and clinical classification of coronavirus disease (COVID-19)","volume":"382","author":"Li","year":"2020","journal-title":"Eur Radiol"},{"key":"2022061708582415200_sct312784-bib-0010","doi-asserted-by":"crossref","first-page":"69","DOI":"10.5582\/bst.2020.01020","article-title":"Drug treatment options for the 2019-new coronavirus (2019-nCoV)","volume":"14","author":"Lu","year":"2020","journal-title":"Biosci Trends"},{"key":"2022061708582415200_sct312784-bib-0011","article-title":"Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review","volume":"(5)","author":"Valk","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"2022061708582415200_sct312784-bib-0012","first-page":"1843","article-title":"Detection of SARS-CoV-2 in different types of clinical specimens","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"2022061708582415200_sct312784-bib-0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2020.101755","article-title":"An update on SARS-CoV-2\/COVID-19 with particular reference to its clinical pathology, pathogenesis, immunopathology and mitigation strategies","author":"Dhama","year":"2020","journal-title":"Travel Med Infect Dis"},{"key":"2022061708582415200_sct312784-bib-0014","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s12098-020-03263-6","article-title":"A review of coronavirus disease-2019 (COVID-19)","volume":"87","author":"Singhal","year":"2020","journal-title":"Indian J Pediatr"},{"key":"2022061708582415200_sct312784-bib-0015","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"2022061708582415200_sct312784-bib-0016","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1148\/radiol.2020200330","article-title":"Use of chest CT in combination with negative RT-PCR assay for the 2019 novel coronavirus but high clinical suspicion","volume":"295","author":"Huang","year":"2020","journal-title":"Radiology"},{"key":"2022061708582415200_sct312784-bib-0017","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jmii.2020.03.005","article-title":"TH17 responses in cytokine storm of COVID-19: an emerging target of JAK2 inhibitor fedratinib","volume":"53","author":"Wu","year":"2020","journal-title":"J Microbiol Immunol Infect"},{"key":"2022061708582415200_sct312784-bib-0018","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/jmv.20255","article-title":"An interferon-gamma-related cytokine storm in SARS patients","volume":"75","author":"Huang","year":"2005","journal-title":"J Med Virol"},{"key":"2022061708582415200_sct312784-bib-0019","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/art.40071","article-title":"Review: cytokine storm syndrome: looking toward the precision medicine era","volume":"69","author":"Behrens","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2022061708582415200_sct312784-bib-0020","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1128\/MMBR.05015-11","article-title":"Into the eye of the cytokine storm","volume":"76","author":"Tisoncik","year":"2012","journal-title":"Microbiol Mol Biol Rev"},{"key":"2022061708582415200_sct312784-bib-0021","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0140-6736(13)61048-X","article-title":"Adult haemophagocytic syndrome","volume":"383","author":"Ramos-Casals","year":"2014","journal-title":"Lancet"},{"key":"2022061708582415200_sct312784-bib-0022","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","article-title":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","volume":"46","author":"Ruan","year":"2020","journal-title":"Intensive Care Med"},{"key":"2022061708582415200_sct312784-bib-0023","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"2022061708582415200_sct312784-bib-0024","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2249.2004.02415.x","article-title":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome","volume":"136","author":"Wong","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"2022061708582415200_sct312784-bib-0025","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.cyto.2018.01.025","article-title":"MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile","volume":"104","author":"Mahallawi","year":"2018","journal-title":"Cytokine"},{"key":"2022061708582415200_sct312784-bib-0026","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"key":"2022061708582415200_sct312784-bib-0027","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s00134-020-06059-6","article-title":"Facing COVID-19 in the ICU: vascular dysfunction, thrombosis, and dysregulated inflammation","volume":"46","author":"Leisman","year":"2020","journal-title":"Intensive Care Med"},{"key":"2022061708582415200_sct312784-bib-0028","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.thromres.2004.03.013","article-title":"D-dimer as marker for microcirculatory failure: correlation with LOD and APACHE II scores","volume":"113","author":"Angstwurm","year":"2004","journal-title":"Thromb Res"},{"key":"2022061708582415200_sct312784-bib-0029","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1007\/s00134-016-4281-z","article-title":"The definition of ARDS revisited: 20\u2009years later","volume":"42","author":"Bernard","year":"2016","journal-title":"Intensive Care Med"},{"key":"2022061708582415200_sct312784-bib-0030","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"2022061708582415200_sct312784-bib-0031","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1172\/JCI60331","article-title":"The acute respiratory distress syndrome","volume":"122","author":"Matthay","year":"2012","journal-title":"J Clin Invest"},{"key":"2022061708582415200_sct312784-bib-0032","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/path.1440","article-title":"The clinical pathology of severe acute respiratory syndrome (SARS): a report from China","volume":"200","author":"Ding","year":"2003","journal-title":"J Pathol"},{"key":"2022061708582415200_sct312784-bib-0033","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1080\/00313020310001619118","article-title":"A clinicopathological study of three cases of severe acute respiratory syndrome (SARS)","volume":"35","author":"Lang","year":"2003","journal-title":"Pathology"},{"key":"2022061708582415200_sct312784-bib-0034","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2022061708582415200_sct312784-bib-0035","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science"},{"key":"2022061708582415200_sct312784-bib-0036","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"2022061708582415200_sct312784-bib-0037","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nm.3028","article-title":"The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine","volume":"19","author":"Bianco","year":"2013","journal-title":"Nat Med"},{"key":"2022061708582415200_sct312784-bib-0038","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.imlet.2015.05.004","article-title":"Mesenchymal stromal cells and the innate immune response","volume":"168","author":"Le Blanc","year":"2015","journal-title":"Immunol Lett"},{"key":"2022061708582415200_sct312784-bib-0039","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/ni.3002","article-title":"Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications","volume":"15","author":"Wang","year":"2014","journal-title":"Nat Immunol"},{"key":"2022061708582415200_sct312784-bib-0040","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/(SICI)1097-4652(199603)166:3<585::AID-JCP13>3.0.CO;2-6","article-title":"Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: effects of dexamethasone and IL-1 alpha","volume":"166","author":"Haynesworth","year":"1996","journal-title":"J Cell Physiol"},{"key":"2022061708582415200_sct312784-bib-0041","first-page":"557","article-title":"Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use","volume":"16","author":"Lazarus","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"2022061708582415200_sct312784-bib-0042","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1002\/sctm.19-0073","article-title":"Mesenchymal stromal cells anno 2019: dawn of the therapeutic era? Concise review","volume":"8","author":"Hoogduijn","year":"2019","journal-title":"Stem Cells Translational Medicine"},{"key":"2022061708582415200_sct312784-bib-0043","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2217\/rme-2018-0171","article-title":"First decade of clinical trials and published studies with mesenchymal stromal cells from umbilical cord tissue","volume":"14","author":"Couto","year":"2019","journal-title":"Regen Med"},{"key":"2022061708582415200_sct312784-bib-0044","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00858-2020","article-title":"Current status of cell-based therapies for respiratory virus infections: applicability to COVID-19","volume":"55","author":"Khoury","year":"2020","journal-title":"Eur Respir J"},{"key":"2022061708582415200_sct312784-bib-0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000849","article-title":"SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism","volume":"6","author":"Frieman","year":"2010","journal-title":"PLoS Pathog"},{"key":"2022061708582415200_sct312784-bib-0046","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.yexcr.2005.03.018","article-title":"Non-hematopoietic bone marrow stem cells: molecular control of expansion and differentiation","volume":"306","author":"Gregory","year":"2005","journal-title":"Exp Cell Res"},{"key":"2022061708582415200_sct312784-bib-0047","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s12015-011-9228-8","article-title":"Bone marrow mesenchymal stem cells: biological properties and their role in hematopoiesis and hematopoietic stem cell transplantation","volume":"7","author":"Pontikoglou","year":"2011","journal-title":"Stem Cell Rev Rep"},{"key":"2022061708582415200_sct312784-bib-0048","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1182\/blood-2004-04-1559","article-title":"Human mesenchymal stem cells modulate allogeneic immune cell responses","volume":"105","author":"Aggarwal","year":"2005","journal-title":"Blood"},{"key":"2022061708582415200_sct312784-bib-0049","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1634\/stemcells.2006-0286","article-title":"Biology of stem cells in human umbilical cord stroma: in situ and in vitro surveys","volume":"25","author":"Karahuseyinoglu","year":"2007","journal-title":"Stem Cells"},{"key":"2022061708582415200_sct312784-bib-0050","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/978-1-60761-999-4_5","article-title":"Isolation, culture, and characterization of human umbilical cord stroma-derived mesenchymal stem cells","volume":"698","author":"Can","year":"2011","journal-title":"Methods Mol Biol"},{"key":"2022061708582415200_sct312784-bib-0051","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.placenta.2014.11.024","article-title":"The assessment of the in vivo to in vitro cellular transition of human umbilical cord multipotent stromal cells","volume":"36","author":"Coskun","year":"2015","journal-title":"Placenta"},{"key":"2022061708582415200_sct312784-bib-0052","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/14653240500319234","article-title":"Clarification of the nomenclature for MSC: the International Society for Cellular Therapy position statement","volume":"7","author":"Horwitz","year":"2005","journal-title":"Cytotherapy"},{"key":"2022061708582415200_sct312784-bib-0053","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s12185-015-1844-7","article-title":"Immunosuppressive properties of Wharton\u2019s jelly-derived mesenchymal stromal cells in vitro","volume":"102","author":"He","year":"2015","journal-title":"Int J Hematol"},{"key":"2022061708582415200_sct312784-bib-0054","article-title":"Human umbilical cord mesenchymal stem cells inhibit the function of allogeneic activated V\u03b39V\u03b42 T lymphocytes in vitro","volume":"2015","author":"Liu","year":"2015","journal-title":"Biomed Res Int"},{"key":"2022061708582415200_sct312784-bib-0055","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1634\/stemcells.2007-1028","article-title":"Immune properties of human umbilical cord Wharton\u2019s jelly-derived cells","volume":"26","author":"Weiss","year":"2008","journal-title":"Stem Cells"},{"key":"2022061708582415200_sct312784-bib-0056","first-page":"65","volume-title":"Mesenchymal Stromal Cells as Tumor Stromal Modulators","author":"Can","year":"2016"},{"key":"2022061708582415200_sct312784-bib-0057","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.jcyt.2017.08.004","article-title":"Umbilical cord mesenchymal stromal cell transplantations: a systemic analysis of clinical trials","volume":"19","author":"Can","year":"2017","journal-title":"Cytotherapy"},{"key":"2022061708582415200_sct312784-bib-0058","first-page":"e71","article-title":"Expanded umbilical cord mesenchymal stem cells (UC-MSCs) as a therapeutic strategy in managing critically ill COVID-19 patients: the case for compassionate use","volume":"23","author":"Atluri","year":"2020","journal-title":"Pain Physician"},{"key":"2022061708582415200_sct312784-bib-0059","doi-asserted-by":"crossref","first-page":"917","DOI":"10.3390\/jcm8070917","article-title":"Adipose tissue stem cells for therapy: an update on the progress of isolation, culture, storage, and clinical application","volume":"8","author":"Chu","year":"2019","journal-title":"J Clin Med"},{"key":"2022061708582415200_sct312784-bib-0060","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.jcyt.2013.02.006","article-title":"Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal\/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT)","volume":"15","author":"Bourin","year":"2013","journal-title":"Cytotherapy"},{"key":"2022061708582415200_sct312784-bib-0061","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.3727\/096368914X685645","article-title":"Adipose tissue-derived mesenchymal stem cells induce expansion of interleukin-10-producing regulatory B cells and ameliorate autoimmunity in a murine model of systemic lupus erythematosus","volume":"24","author":"Park","year":"2015","journal-title":"Cell Transplant"},{"key":"2022061708582415200_sct312784-bib-0062","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1634\/stemcells.2006-0228","article-title":"Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease","volume":"24","author":"Yanez","year":"2006","journal-title":"Stem Cells"},{"key":"2022061708582415200_sct312784-bib-0063","doi-asserted-by":"crossref","first-page":"13625","DOI":"10.1073\/pnas.240309797","article-title":"Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo","volume":"97","author":"Gronthos","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061708582415200_sct312784-bib-0064","doi-asserted-by":"crossref","first-page":"604","DOI":"10.4252\/wjsc.v11.i9.604","article-title":"Immunomodulatory properties of dental tissue-derived mesenchymal stem cells: implication in disease and tissue regeneration","volume":"11","author":"Andrukhov","year":"2019","journal-title":"World J Stem Cells"},{"key":"2022061708582415200_sct312784-bib-0065","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.joen.2010.12.012","article-title":"Expression pattern of Oct-4, Sox2, and c-Myc in the primary culture of human dental pulp derived cells","volume":"37","author":"Liu","year":"2011","journal-title":"J Endod"},{"key":"2022061708582415200_sct312784-bib-0066","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1097\/01.tp.0000173794.72151.88","article-title":"Multipotent mesenchymal stem cells with immunosuppressive activity can be easily isolated from dental pulp","volume":"80","author":"Pierdomenico","year":"2005","journal-title":"Transplantation"},{"key":"2022061708582415200_sct312784-bib-0067","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/4682875","article-title":"The comparison of the immunologic properties of stem cells isolated from human exfoliated deciduous teeth, dental pulp, and dental follicles","volume":"2016","author":"Yildirim","year":"2016","journal-title":"Stem Cells Int"},{"key":"2022061708582415200_sct312784-bib-0068","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41581-018-0023-5","article-title":"Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases","volume":"14","author":"Shi","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"2022061708582415200_sct312784-bib-0069","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.4049\/jimmunol.0803055","article-title":"C3a and C5a are chemotactic factors for human mesenchymal stem cells, which cause prolonged ERK1\/2 phosphorylation","volume":"182","author":"Schraufstatter","year":"2009","journal-title":"J Immunol"},{"key":"2022061708582415200_sct312784-bib-0070","doi-asserted-by":"crossref","DOI":"10.1038\/srep38308","article-title":"Human mesenchymal stem cells program macrophage plasticity by altering their metabolic status via a PGE(2)-dependent mechanism","volume":"6","author":"Vasandan","year":"2016","journal-title":"Sci Rep"},{"key":"2022061708582415200_sct312784-bib-0071","doi-asserted-by":"crossref","first-page":"e8151","DOI":"10.1073\/pnas.1614935113","article-title":"TNF\u03b1-stimulated gene-6 (TSG6) activates macrophage phenotype transition to prevent inflammatory lung injury","volume":"113","author":"Mittal","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061708582415200_sct312784-bib-0072","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/s41418-017-0006-2","article-title":"Kynurenic acid, an IDO metabolite, controls TSG-6-mediated immunosuppression of human mesenchymal stem cells","volume":"25","author":"Wang","year":"2018","journal-title":"Cell Death Differ"},{"key":"2022061708582415200_sct312784-bib-0073","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.stem.2014.06.008","article-title":"Leptin-receptor-expressing mesenchymal stromal cells represent the main source of bone formed by adult bone marrow","volume":"15","author":"Zhou","year":"2014","journal-title":"Cell Stem Cell"},{"key":"2022061708582415200_sct312784-bib-0074","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/term.137","article-title":"Reverse remodeling is associated with changes in extracellular matrix proteases and tissue inhibitors after mesenchymal stem cell (MSC) treatment of pressure overload hypertrophy","volume":"3","author":"Molina","year":"2009","journal-title":"J Tissue Eng Regen Med"},{"key":"2022061708582415200_sct312784-bib-0075","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.exphem.2007.05.012","article-title":"Injured microenvironment directly guides the differentiation of engrafted Flk-1(+) mesenchymal stem cell in lung","volume":"35","author":"Yan","year":"2007","journal-title":"Exp Hematol"},{"key":"2022061708582415200_sct312784-bib-0076","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1620\/tjem.236.209","article-title":"Therapeutic potential of umbilical cord mesenchymal stem cells for inhibiting myofibroblastic differentiation of irradiated human lung fibroblasts","volume":"236","author":"Zhang","year":"2015","journal-title":"Tohoku J Exp Med"},{"key":"2022061708582415200_sct312784-bib-0077","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1089\/scd.2013.0479","article-title":"Mesenchymal stem cells secrete immunologically active exosomes","volume":"23","author":"Zhang","year":"2014","journal-title":"Stem Cells Dev"},{"key":"2022061708582415200_sct312784-bib-0078","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1083\/jcb.201211138","article-title":"Extracellular vesicles: exosomes, microvesicles, and friends","volume":"200","author":"Raposo","year":"2013","journal-title":"J Cell Biol"},{"key":"2022061708582415200_sct312784-bib-0079","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/sctm.19-0114","article-title":"Mesenchymal stromal cell-derived extracellular vesicles for regenerative therapy and immune modulation: progress and challenges toward clinical application","volume":"9","author":"Allan","year":"2020","journal-title":"Stem Cells Translational Medicine"},{"key":"2022061708582415200_sct312784-bib-0080","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s10571-016-0366-z","article-title":"Introduction to extracellular vesicles: biogenesis, RNA cargo selection, content, release, and uptake","volume":"36","author":"Abels","year":"2016","journal-title":"Cell Mol Neurobiol"},{"key":"2022061708582415200_sct312784-bib-0081","doi-asserted-by":"crossref","first-page":"608","DOI":"10.3389\/fimmu.2014.00608","article-title":"Extracellular vesicles: potential roles in regenerative medicine","volume":"5","author":"De Jong","year":"2014","journal-title":"Front Immunol"},{"key":"2022061708582415200_sct312784-bib-0082","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.imlet.2015.06.007","article-title":"The secretome of mesenchymal stromal cells: role of extracellular vesicles in immunomodulation","volume":"168","author":"Bruno","year":"2015","journal-title":"Immunol Lett"},{"key":"2022061708582415200_sct312784-bib-0083","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jcyt.2015.10.011","article-title":"Mesenchymal stromal cells and immunomodulation: a gathering of regulatory immune cells","volume":"18","author":"Najar","year":"2016","journal-title":"Cytotherapy"},{"key":"2022061708582415200_sct312784-bib-0084","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-19211-6","article-title":"Efficient scalable production of therapeutic microvesicles derived from human mesenchymal stem cells","volume":"8","author":"Cha","year":"2018","journal-title":"Sci Rep"},{"key":"2022061708582415200_sct312784-bib-0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21030799","article-title":"Perspectives for future use of extracellular vesicles from umbilical cord- and adipose tissue-derived mesenchymal stem\/stromal cells in regenerative therapies-synthetic review","volume":"21","author":"Lelek","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2022061708582415200_sct312784-bib-0086","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1136\/thoraxjnl-2011-201059","article-title":"Mesenchymal stem cells enhance recovery and repair following ventilator-induced lung injury in the rat","volume":"67","author":"Curley","year":"2012","journal-title":"Thorax"},{"key":"2022061708582415200_sct312784-bib-0087","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/thoraxjnl-2018-211576","article-title":"Therapeutic effects of human mesenchymal stem cell microvesicles in an ex vivo perfused human lung injured with severe E. coli pneumonia","volume":"74","author":"Park","year":"2019","journal-title":"Thorax"},{"key":"2022061708582415200_sct312784-bib-0088","doi-asserted-by":"crossref","first-page":"L809","DOI":"10.1152\/ajplung.00358.2013","article-title":"Clinical grade allogeneic human mesenchymal stem cells restore alveolar fluid clearance in human lungs rejected for transplantation","volume":"306","author":"McAuley","year":"2014","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2022061708582415200_sct312784-bib-0089","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nm.2736","article-title":"Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury","volume":"18","author":"Islam","year":"2012","journal-title":"Nat Med"},{"key":"2022061708582415200_sct312784-bib-0090","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms9472","article-title":"Mesenchymal stem cells use extracellular vesicles to outsource mitophagy and shuttle microRNAs","volume":"6","author":"Phinney","year":"2015","journal-title":"Nat Commun"},{"key":"2022061708582415200_sct312784-bib-0091","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1002\/stem.2372","article-title":"Mitochondrial transfer via tunneling nanotubes is an important mechanism by which mesenchymal stem cells enhance macrophage phagocytosis in the in vitro and in vivo models of ARDS","volume":"34","author":"Jackson","year":"2016","journal-title":"Stem Cells"},{"key":"2022061708582415200_sct312784-bib-0092","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1164\/rccm.201701-0107CP","article-title":"Fifty years of research in ARDS. Cell-based therapy for acute respiratory distress syndrome. Biology and potential therapeutic value","volume":"196","author":"Laffey","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"2022061708582415200_sct312784-bib-0093","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/ALN.0000000000000545","article-title":"Therapeutic efficacy of human mesenchymal stromal cells in the repair of established ventilator-induced lung injury in the rat","volume":"122","author":"Hayes","year":"2015","journal-title":"Anesthesiology"},{"key":"2022061708582415200_sct312784-bib-0094","doi-asserted-by":"crossref","first-page":"L975","DOI":"10.1152\/ajplung.00242.2013","article-title":"Conditioned media from mesenchymal stromal cells restore sodium transport and preserve epithelial permeability in an in vitro model of acute alveolar injury","volume":"306","author":"Goolaerts","year":"2014","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2022061708582415200_sct312784-bib-0095","doi-asserted-by":"crossref","first-page":"26211","DOI":"10.1074\/jbc.M110.119917","article-title":"Allogeneic human mesenchymal stem cells restore epithelial protein permeability in cultured human alveolar type II cells by secretion of angiopoietin-1","volume":"285","author":"Fang","year":"2010","journal-title":"J Biol Chem"},{"key":"2022061708582415200_sct312784-bib-0096","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1164\/rccm.201206-0990OC","article-title":"Therapeutic effects of human mesenchymal stem cells in ex vivo human lungs injured with live bacteria","volume":"187","author":"Lee","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2022061708582415200_sct312784-bib-0097","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.3892\/mmr.2014.3092","article-title":"Paracrine factors from mesenchymal stem cells attenuate epithelial injury and lung fibrosis","volume":"11","author":"Shen","year":"2015","journal-title":"Mol Med Rep"},{"key":"2022061708582415200_sct312784-bib-0098","doi-asserted-by":"crossref","first-page":"875","DOI":"10.4049\/jimmunol.1500244","article-title":"Human mesenchymal stem (stromal) cells promote the resolution of acute lung injury in part through lipoxin A4","volume":"195","author":"Fang","year":"2015","journal-title":"J Immunol"},{"key":"2022061708582415200_sct312784-bib-0099","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1164\/rccm.201410-1765OC","article-title":"Therapeutic effects of human mesenchymal stem cell-derived microvesicles in severe pneumonia in mice","volume":"192","author":"Monsel","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"2022061708582415200_sct312784-bib-0100","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1111\/ajt.13271","article-title":"Microvesicles derived from human mesenchymal stem cells restore alveolar fluid clearance in human lungs rejected for transplantation","volume":"15","author":"Gennai","year":"2015","journal-title":"Am J Transplant"},{"key":"2022061708582415200_sct312784-bib-0101","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1089\/107999000312423","article-title":"Regulation of macrophage interleukin-6 (IL-6) and IL-10 expression by prostaglandin E2: the role of p38 mitogen-activated protein kinase","volume":"20","author":"Williams","year":"2000","journal-title":"J Interferon Cytokine Res"},{"key":"2022061708582415200_sct312784-bib-0102","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1002\/stem.544","article-title":"Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37","volume":"28","author":"Krasnodembskaya","year":"2010","journal-title":"Stem Cells"},{"key":"2022061708582415200_sct312784-bib-0103","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010088","article-title":"A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an immunosuppressive MSC2 phenotype","volume":"5","author":"Waterman","year":"2010","journal-title":"PLoS One"},{"key":"2022061708582415200_sct312784-bib-0104","doi-asserted-by":"crossref","DOI":"10.1002\/sctm.20-0146","article-title":"Cell-based therapy to reduce mortality from COVID-19: systematic review and meta-analysis of human studies on acute respiratory distress syndrome","volume":"9","author":"Qu","year":"2020","journal-title":"Stem Cells Translational Medicine"},{"key":"2022061708582415200_sct312784-bib-0105","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1465-9921-15-39","article-title":"Treatment of acute respiratory distress syndrome with allogeneic adipose-derived mesenchymal stem cells: a randomized, placebo-controlled pilot study","volume":"15","author":"Zheng","year":"2014","journal-title":"Respir Res"},{"key":"2022061708582415200_sct312784-bib-0106","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3346\/jkms.2014.29.3.438","article-title":"Intratracheal administration of umbilical cord blood-derived mesenchymal stem cells in a patient with acute respiratory distress syndrome","volume":"29","author":"Chang","year":"2014","journal-title":"J Korean Med Sci"},{"key":"2022061708582415200_sct312784-bib-0107","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S2213-2600(14)70291-7","article-title":"Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial","volume":"3","author":"Wilson","year":"2015","journal-title":"Lancet Respir Med"},{"key":"2022061708582415200_sct312784-bib-0108","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.5966\/sctm.2015-0021","article-title":"In vivo effects of mesenchymal stromal cells in two patients with severe acute respiratory distress syndrome","volume":"4","author":"Simonson","year":"2015","journal-title":"Stem Cells Translational Medicine"},{"key":"2022061708582415200_sct312784-bib-0109","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S2213-2600(18)30418-1","article-title":"Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial","volume":"7","author":"Matthay","year":"2019","journal-title":"Lancet Respir Med"},{"key":"2022061708582415200_sct312784-bib-0110","doi-asserted-by":"crossref","first-page":"e391","DOI":"10.1097\/CCM.0000000000004285","article-title":"Human umbilical cord-derived mesenchymal stem cells for acute respiratory distress syndrome","volume":"48","author":"Yip","year":"2020","journal-title":"Crit Care Med"},{"key":"2022061708582415200_sct312784-bib-0111","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/5432134","article-title":"Strategies to enhance mesenchymal stem cell-based therapies for acute respiratory distress syndrome","volume":"2019","author":"Han","year":"2019","journal-title":"Stem Cells Int"},{"key":"2022061708582415200_sct312784-bib-0112","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0140-6736(20)30317-2","article-title":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury","volume":"395","author":"Russell","year":"2020","journal-title":"Lancet"},{"key":"2022061708582415200_sct312784-bib-0113","author":"Chinese Clinical Trial Registry"},{"key":"2022061708582415200_sct312784-bib-0114","author":"Liang"},{"key":"2022061708582415200_sct312784-bib-0115","doi-asserted-by":"crossref","first-page":"216","DOI":"10.14336\/AD.2020.0228","article-title":"Transplantation of ACE2\u2212 mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia","volume":"11","author":"Leng","year":"2020","journal-title":"Aging Dis"},{"key":"2022061708582415200_sct312784-bib-0116","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1089\/scd.2020.0071","article-title":"Stem cell-based therapy for coronavirus disease 2019","volume":"29","author":"Zhao","year":"2020","journal-title":"Stem Cells Dev"},{"key":"2022061708582415200_sct312784-bib-0117","doi-asserted-by":"crossref","first-page":"477","DOI":"10.14336\/AD.2020.0403","article-title":"Mesenchymal stem cells for coronavirus (COVID-19)-induced pneumonia: revisiting the paracrine hypothesis with new hopes?","volume":"11","author":"Ozt\u00fcrk","year":"2020","journal-title":"Aging Dis"},{"key":"2022061708582415200_sct312784-bib-0118","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102433","article-title":"The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak","volume":"109","author":"Rothan","year":"2020","journal-title":"J Autoimmun"},{"key":"2022061708582415200_sct312784-bib-0119","doi-asserted-by":"crossref","DOI":"10.1016\/j.medidd.2020.100019","article-title":"Mesenchymal stem cells and management of COVID-19 pneumonia","volume":"5","author":"Metcalfe","year":"2020","journal-title":"Med Drug Discov"},{"key":"2022061708582415200_sct312784-bib-0120","volume-title":"The American Academy of Stem Cell Physicians Recommends A Treatment Protocol for COVID-19 to the WHO. News release","author":"American Academy of Stem Cell Physicians","year":"2020"},{"key":"2022061708582415200_sct312784-bib-0121","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.stem.2020.05.003","article-title":"Preying on public fears and anxieties in a pandemic: businesses selling unproven and unlicensed \u201cstem cell treatments\u201d for COVID-19","volume":"26","author":"Turner","year":"2020","journal-title":"Cell Stem Cell"}],"container-title":["Stem Cells Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fsctm.20-0164","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/sctm.20-0164","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/sctm.20-0164","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/stcltm\/article-pdf\/9\/11\/1287\/44114280\/stcltm_9_11_1287.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/stcltm\/article-pdf\/9\/11\/1287\/44114280\/stcltm_9_11_1287.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T09:00:32Z","timestamp":1655456432000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/stcltm\/article\/9\/11\/1287\/6407001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,21]]},"references-count":121,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,7,21]]},"published-print":{"date-parts":[[2020,11,1]]}},"URL":"https:\/\/doi.org\/10.1002\/sctm.20-0164","relation":{},"ISSN":["2157-6564","2157-6580"],"issn-type":[{"value":"2157-6564","type":"print"},{"value":"2157-6580","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,11,1]]},"published":{"date-parts":[[2020,7,21]]},"assertion":[{"value":"2020-04-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-23","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}